LYMPHOKINE INDUCING TERMINAL DIFFERENTIATION OF THE HUMAN MONOBLAST LEUKEMIA LINE U937 - A ROLE FOR GAMMA-INTERFERON
- 1 January 1983
- journal article
- research article
- Vol. 62 (6), 1169-1175
Abstract
The human monoblast leukemia line, U937, is growth-inhibited and induced to develop markers of mature monocytes by lymphokine preparations. Lymphokine is cytostatic and induces expression of Fc receptors in U937 and in myelomonocytic leukemic lines RC-2A and KG-1, but does not have these effects on T- and B-lymphocytic lines. In addition to previously described properties, including complement receptors, phagocytosis and antibody-dependent cellular cytotoxicity (ADCC), Mac-1 and Mac-3 surface antigens defined by monoclonal antibodies are induced on U937 cells by lymphokine and phorbol ester. The Mac-1 surface component appears to have a regulatory role in differentiation of the monocyte lineage line, since antibodies to this antigen block the induction of Mac-3 antigen. The lymphokine activity was concentrated by salt precipitation and characterized by ion-exchange and size chromatography. Fractions of .apprx. 40,000 daltons (40 K) were responsible for growth inhibition and induction of Fc receptors and Mac-1 antigen in U937 cells. However, ADCC was not induced in U937 cells. However, ADCC was not induced in U937 by individual fractions of lymphokine, suggesting that this cytotoxic capacity may be regulated by a lymphokine of a different size, which is only effective after initial maturation steps. Since .gamma.-interferon is present on the 40K size range of lymphokine, the possibility that interferon is a differentiation modulator for the monoblast cells was investigated. Highly purified .gamma.-interferon (107 U/mg protein) at 10-300 U/ml inhibited growth and induced Fc receptors in U937 similar to the effect of lymphokine. The Fc-receptor-inducing activity of lymphokine was inhibited by a neutralizing monoclonal antibody to .gamma.-interferon, suggesting that this differentiation factor in lymphokine is .gamma.-interferon. [The implications of this research for cancer therapy are discussed].This publication has 27 references indexed in Scilit:
- Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection.The Journal of Immunology, 1981
- STIMULATION OF A HUMAN MACROPHAGE-LIKE CELL-LINE (U-937) TO INHIBIT MULTIPLICATION OF AN INTRACELLULAR PATHOGEN1981
- Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.The Journal of Immunology, 1981
- Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.Proceedings of the National Academy of Sciences, 1980
- Differentiation and production of colony-stimulating factor induced by immunostimulants in a leukemia cell lineJournal of Cellular Physiology, 1980
- Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions.The Journal of Immunology, 1980
- Separation of different molecular forms of macrophage‐ and granulocyte‐inducing proteins for normal and leukemic myeloid cellsInternational Journal of Cancer, 1980
- Endogenous pyrogen production by Hodgkin's disease and human histiocytic lymphoma cell lines in vitro.Journal of Clinical Investigation, 1980
- SURVIVAL OF MICE INOCULATED WITH NON-DIFFERENTIATING MYELOID-LEUKEMIA CELLS IS PROLONGED BY THE INJECTION OF AN INDUCER OF CELL-DIFFERENTIATION WITH A SENSITIZER1980
- Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.The Journal of Experimental Medicine, 1976